|
1. 賴永勳，黃尚志，楊五常暨中華民國腎臟醫學會透析評估委員：
臺灣地區八十六年度透析評估報告。p177-179 , p188
2. Andrassy K, Bommer ER: Effects of Hemodialysis on platelet.
Contr.Nephrol. 1987; 59: 26-34
3. Hakim RM, Schafer Al: hemodialysis-associated platelet activation
and thrombocytopenia. Am. J. Med. 1985; 78: 575-580
4. Sreeharan N, Crow MJ, Salter MCP et al: membrane effect on plate-
let function during hemodialysis: A comparison of cuprophan and po-
lycarbonate. Artif. Organs. 1982; 324-327
5. Raij L , Kay NE: Effect of Hemodialysis membranes on humen lym-
phocyte natural killer function. Nephrol., vol.59, 17-25
( karger , basel 1987 )
6. Geyo F, Yamada T, Odani S et al: a new form of amyloid associated
with chronic hemodialysis was identified as β2-microglobulin .
Biochem. Biophys. Res. Commun. 1985; 129: 701-706
7. Nelon, A. R., Fingleton, B., Rothenberg, M. L and Matrisian, L.M
Matrix metalloproteinase : biological activity and clinical implication
J. Clin. Oncol. 2000; 18: 1135-1149 8. Woessner, J.F.Jr The matrix metalloproteinase family, in Parks WC,
Mecham RP (eds): Matrix metalloproteinase. San Diego, CA ,
Academic Press, 1998: 1-14
9. Fini, M. E., Cook, J. R., Mohan, R, et al. Regulatio of gene expres-
sion in parks WC, Mwcham, R. P. (eds): Matrix metalloproteases.
San Diego, CA, Academic press 1998: 299-256
10. Kugler, A: Matrix Metalloproteinases and their inhibitors.
Anticancer Res. 1999; 19: 1589-1592
11. Murphy, G., Reynolds, J. J. and hembry, R . M .: Metalloproteinases
and cancer invasion and metastasis. Int. J.Cancer 1992; 44: 757-760
12. Murphy, G. and Docherty, A . J: Matrix metalloproteinases and their
inhibitors. Am. J. Respir. Cell Mel. Biol. 1992; 7: 120-125
13. Gomez, D. E., Alonso, D. F., Yoshiji, H. and Thorgeirsson, U.P:
Tissue inhibitor of metalloproteinases: structure, regulation and bi-
ological functions. Eur. J. Cell Biol. 1997; 74: 111-122
14. Hueboner, K., Isobe, M., Gasson, J.C., Golde, D.W. and Croce ,C.
M : Localization of the gene encoding erythroid-potentiating activ-
ity to chromosome region Xpll. 1- Xpll. 4. Am. J. Hum. Genet. 1986
; 38: 819-826
15. Woessener, J. F. : Matrix metalloproteinases and their inhibitors in
connective tissue remodeling. FASEB J. 1991; 5: 2145-2155
16. Kolkenbrock, H., Hecker, A., Zimmermann, J. and Ulbrich, N.
: Generation and activity of ternary gelatinase B/TIMP-1/LMW-str-
omelysin-1 complex. Biol. Chem. Hoppe. 1995; Seyler 376: 495-500
17. Goldberg, G. I., Strongin, A., Collier, I.E., Genrich, L. T. and Marmer
, B. L.: Interaction of 92-kDa type Ⅳcollagenase with the tissue inh-
ibitor of metalloproteinase prevents dimerziation , complex formation
with interstital collagenase , and activation of the proenzyme with st-
romelysin. J. Biol. Chem. 1992; 267: 4583-4591
18. Johnson, M. D., Kim, H. R., Chesler, L., Tsao, W. G., Bouck, N.
and Polverini, P. J.: Inhibition of angiogenesis by tissue inhibitor of
metalloprotrinase. J. Cell Physiol. 1994; 160: 194-202
19. Takigawa, M., Nishida, Y., Suzuki, F., Kishi, J., Yamashita, K . and
Hayakawa, T.: Induction of angiogenesis in chick yolksac membrane
by polyamines and its inhibition by tissue inhibitor of metalloprotein-
ases ( TIMP-1 and TIMP-2 ). Biochem. Biophys. Res.1990; 171:1264
1271
20. Thorgeirsson, U. P., Yoshiji, H., Sinha C. C. and Gomez, D. E.:
Breast cancer : tumor neovasculature and the effect of tissue inhibi-
tor of metalloproteinase-1 (TIMP-1) on angiogenesis. In Vivo. 1996
; 10: 137-144
21. Alvarez, O. A., Carmichael, D. E. and DeClerck, Y. A. : Inhibition
of collagenolytic activity and metastasis of tumor cells by a recombi-
nant human tissue inhibitor of metalloproteinases. J. Natl. Cancer Inst
1990; 82: 589-595
22. DeClerck, Y. A., Perez, N., Shimada, H., Boone, T. C., Langley, K. E.
and Taylor, S. M. : Inhibition of invasion and metastasis in cell transf-
ected with an inhibitor of metalloproteinases. Cancer Res. 1992; 52:
701-708
23. Schultz, R. M., Silberman, S., Persky, B., Bajkowski, A. S. and
Carmichael, D. F.: Inhibition of human recombinant tissue inhibitor
of metalloproteinase of human amnion invasion and lung colonization
by murine B16-F10 melanoma cells. Cancer Res. 1988; 48:5539-5545
24. Thorgeirsson, U. P., Liotta, L. A., Kalebic, T., Margulies, I. M.,
Thomas, K., Rios. Candelore, M. and Russo R. G.: Effect of natural
protease inhibitors and a chemoattractant on tumor cell invasion in
vitro. J. Natl. Cancer Inst. 1982; 69: 1049-1054
25. Flenniken, A. M. and Williams, B. R. : Developmental expression of
the endogenousTIMP gene and a TIMP-lacZ fusion gene in transgenic
mice. Genes Dev. 1990; 4: 1094-1106
26. DeClerk, Y. A., Szpirer, C., Aly, M. S., Cassiman, J. J., Eeckhout, Y.
and Rousseau, G.: The gene for tissue inhibitor of metallproteinase-2
is localizied on human chromosome arm 17q25. Genomics 1992; 14:
782-784
27. Boone, T. C., Johnson, M. J., DeClerck, Y. A. and langley, K. E.
: cDNA cloning and expression of a metalloproteinase inhibitor rela-
ted to inhibitor of metalloproteinases. Proc. Natl. Acad. Sci.USA
1990; 87: 2800-2804
28. Shapiro, S. D., Kobayashi, D. K. and Welgus. H. G. : Idetification of
TIMP-2 in human alveolar macrophages. J. Biol. Chem. 1992; 267:
13890-13894
29. Stetler-Stevenson, W. G., Brown, P. D. Onisto, M., Levy, A. T. and
Liotta, L. A.: Tissue inhibitor of metalloproteinase -2(T-IMP-2)
mRNA expression in tumor cell lines and human tumor tissue. J.
J. Biol.Chem. 1990; 265: 13933-13938
30. Apte, S. S., Olaen, B. R. and Murphy, G. : The gene structure of tiss-
ue inhibitor of metalloproteinase (TIMP-3) and its inhibitor activaties
define the distint TIMP gene family. J. Biol. Chem. 1995; 270: 14313
-14318
31. Leco, K. J., Khokha, R., Pavloff, N., Hawkes, S. P. and Edwards, D. R
. : Tissue inhibitor of metalloproteinase-3 (TIMP-3) is an eetracellular
matrix-associated protein with a distinctive pattern of expression in
mouse cells and tissues. J. Biol.Chem. 1994; 269: 9352-9360
32. Stricklin, G. P. and Welgus, H. G. : Human skin fibroblast collagenase
inhibitors: purification and biological characterization. J. Biol. Chem.
1983; 258: 12252-12258
33. Yang, T. T. and Hawkes, S. P.: Role of the 21-kDa protein TIMP-3 in
in oncogenic transformation of cultured chicken embryofibroblast .
Proc. Natl. Acad. Sci. USA 1992; 89: 10676-10680
34. Wick, M., Burger, C., Bnsselbach, S., Lucibello, E. and Muller, R.
: A novel member of human tissue inhibitor of metalloproteinases
(TIMP) gene family is regulated during GI progression, mitogenic
stimulation, diferentiation and senescence. J. Biol. Chem. 1994; 269:
18953-18960
35. Greene, J., Wang, M., Liu, Y. E., Raymond, L. A., Rosen, C. and
Shi, Y. E. : Molecular colning and characterization of human tissue
inhibitor of metalloproteinase 4. J. Biol.Chem. 1996; 271: 30375-
30380
36. Schaefer, R. M., Paczek. L. and Heidland. A.: Cytokine Production
by Monocytes During Haemodialysis. Nephrol. Dial. Transplant.
1991; suppl 2: 14-17
37. Betz M, Haensch GM, Rauterberg EW, Bommer J, Ritz E.: Cupram-
monium membranes stimulate interlukin-1 release and arachidonic
acid metabolism in monocytes in the absence of complement .
Kidney Int. 1988; 34: 67-73
38. Raymond M. Hakin, Douglas T. Fearon, and J. Michael Lazarus.
: Biocompatibility of dialysis membranes: Effect of chronic comple-
ment activation. Kideny Int. 1984; 26: 194-200
39. Trang DC, Huang TP, Liu TY, Chen HW, Sung YJ, Wei YH.: Effect
of vitamin E-bounded membrane on the 8-hydroxy 2'-deoxyguanos-
ine level in leukocyte DNA of hemodialysis patients. Kidney Int.2000
; 58: 790-799
40. Kleinmon KS, Coburn JW: Amyloid syndrome associated with hem-
odialysis. Kindney Int. 1989; 35: 567-575
41. Stone WJ, Hakim RM: Beta-2-microglobulin amyloidosis in long-te-
rm dialysis patients. Kidney Int. 1989; 35: 177-183
42. Floege J, Granolleras C, Koch KM, Shaldon S: Which membrane ?
Should beta-2 microglobulin decide on the choice of today's hemodia-
lysis membrane ? Nephron. 1988; 50: 177-181
43. Raymond M. Hakim, rebecca L. Wingard, Leigh Husni, Robert A.
Parker, and Tom F. ParkerⅢ: The effect of membrane biocompatibi-
lity on plasma β2-microglobulin level s in chronic hemodialysis pat-
ients. J. Am. Soc. Nephrol. 1996; 7: 472-478
44. Ebihara I, Nakamura T, Tomino Y, Shimada N, Koide H: Metallopro-
teinase-9 mRNA expression in monocytes from patients with chronic
renal failure. Am. J. Nephrol. 1998; 18: 305-310
45. Ohashi K, Kawai R, Hara M, Okada Y, Tachibana S, Ogura Y:
Increased matrix metalloproteinases as possible cause of osseoarti-
cular tissue destruction in long-term haemodialysis and beta 2-micr-
oglobulin amyloidosis. Virchows Arch. 1996; 428: 37-46
46. Gutierrez A, Alvestrand A, Wahren J, Bergstrom J: Effect of in vivo
contact between blood and dialysis membranes on protein catabolism
in humans. Kidney Int. 1990; 38: 487-494
47. Tayeb JS, Provenzano R, El-Ghoroury M, Bellovich K, Khairullah Q,
Pieper D, Morrison L. Calleja Y: Effect of biocompatibility of hemo-
dialysis membranes on serum albumin levels. Am. J. Kidney Disease.
2000; 35: 606-610
48. Lin YF, Chang DM, Shaio MF, Lu KC, Chyr SH, Li BL, Sheih SD
: Cytokine production during hemodialysis : effects of dialytic me-
mbrane and complement activation. Am. J. Nephrol. 1996; 16: 293-
299
49. Himmelfarb J, Hakim RM: The use of biocompatible dialysis mem-
branes in acute renal failure.Adv Ren Replace Ther. 1997; 4: 72-80
50. Buoncristiani U, Galli F, Rovidati S, Albertini MC, Campus G, Can-
estrari F: Oxidative damage during hemodailysis using a vitamin-E
modified dialysis membrane: a preliminary characterization. Nephrol.
1997; 77: 57-61
51. Johnatty RN, Taub DD, Reeder SP, Turcovski-Corrales SM, Cottam
DW, Stephenson TJ, Rees RC: Cytokine and chemokine regulation of
pro-MMP-9 and TIMP-1 production by human peripheral blood lyph-
ocytes. J. Immunol. 1997; 158: 2327-2333
52. Goetzl EJ, Banda MJ, Leppert D: Matrix metalloproteinases in immu-
nity. J Immunol. 1996; 159-6 : 1-4
53. Sasaki K, Hattori T, Fujisawa T, Takahashi K, Inoue H, Takigawa M
Nitric oxide mediates interlukin-1-induced gene expression of metal-
loproteinases and basic fibroblast growth factor in cultured rabbit arti-
cular chondrocytes. J. Biochem. (Tokyo). 1998; 123; 431-439
54. Rajagopalan S, Meng XP, Ramasmy S, Harrison DG, Galis ZS:
Reactive oxygen species produced by macrophage-dervied foam ce-
lls regulate the activity of vascular matrix metalloproteinases in vitro.
J. Clin. Invest. 1996; 98; 2572-2579
55. Hi YE, Liu Y: Stromal-epithelial interaction in type Ⅵ collagenase
expression and activation: The role in cancer metastasis. In: Goldberg
ID, Rasan EM (eds): Epithelial-Mesenchymal Interations in Cancer.
Switzerland, Birkhausar Berlag Basel, 1995, pp215-234
56. Garzetti GG, Ciavattini A, Lucarini G, Goteri G, Romanini C, Biag-
ini G: Increased serum 72 Kda metalloproteinase in serous ovarian
tumors: comparsion with CA125. Anticancer Res. 1996; 16: 2123-
2127
57. Hayasaka A, Suzuki N, Fujimoto N, Iwama S, Fukuyama E, Kanda Y,
Saisho H: Elevated plasma levels of matrix metalloproteinase-9 (92-
-kd typeⅥ collagenase/gelatinase B) in hepatocellular carcinoma.
Hepatology 1996; 24: 1058-1062
58. Moore DH, Allison B, Look KY, Sutton GP, Bigsby RM: Collagenase
expression in orvarian cancer cell line. Gynecol. Oncol. 1997;65: 78-
82
59. Endo K, Maehara Y, Baba H, Yamamoto M, Tomissaki S, Watanabe
A, Kakeji Y. Sugimachi K: Elevated levels of serum plasma metallo-
proteinases in patients with gastric cancer. Anticancer Res. 1997; 17
: 2253-2258
60. Celentano DC, Frishman WH: Matrix metalloproteinases and cornoa-
ry artery disease: a novel therapeutic target. J. Clin. Pharmacol. 1997;
37: 991-1000
61. Ohashi K: Pathogenesis of beta-2 microglobulin amyloidosis .
Path. Int. 2001; 51: 1-10
|